The information on this site is intended for healthcare professionals involved in the delivery of critical care. By entering, you confirm you are a qualified healthcare professional or an authorised representative.
Critical care is the branch of medicine for patients whose organs are failing or at risk of failing. An ICU is a specialised ward where technology replaces or supports organ function — breathing, circulation, kidney filtration — while the body heals. Every device is a bridge: buying time, supporting a failing system, or providing data that changes the next clinical decision. That's the space TheronTech occupies.
Each division addresses a specific domain of organ support — from respiratory failure to renal replacement to neonatal intensive care.
A mechanical ventilator breathes for a patient who cannot.
Invasive and non-invasive mechanical ventilation for adult through neonatal patients. Adaptive pressure support, volume-targeted modes, integrated lung mechanics monitoring, and automated recruitment tools. Designed around lung-protective strategy principles established by the ARDSNet protocol.1
An ECMO circuit takes over the work of the heart, the lungs, or both.
Veno-venous (VV) and veno-arterial (VA) extracorporeal membrane oxygenation for cardiopulmonary failure refractory to conventional management. Integrated centrifugal pump, polymethylpentene oxygenator, and real-time monitoring of transmembrane pressures, SvO₂, and circuit flows.2,3
A CRRT machine performs the kidney's job of filtering blood continuously over hours or days.
Continuous renal replacement therapy for acute kidney injury in the critically ill. Supports CVVH, CVVHD, and CVVHDF modalities. Integrated citrate anticoagulation protocol, automated fluid balance management, and effluent dose tracking aligned with KDIGO guideline recommendations.4,5
Hemodynamic monitors measure pressures, flows, and oxygen delivery inside the cardiovascular system in real time.
Minimally invasive and non-invasive hemodynamic assessment. Continuous cardiac output, stroke volume variation (SVV), systemic vascular resistance, and dynamic preload indices via arterial waveform analysis. Optional transpulmonary thermodilution module.
Infusion pumps deliver medications in precise, programmable doses measured in fractions of a millilitre.
Modular infusion platform supporting syringe drivers for vasoactive medications and volumetric pumps for fluid and nutrition delivery. Drug library with configurable hard and soft dose limits, DERS (Dose Error Reduction System), bolus management, and multi-pump stacking.
High-flow nasal cannula delivers heated, humidified oxygen to support breathing before a ventilator is needed.
Heated, humidified high-flow oxygen delivery up to 80 L/min with precise FiO₂ titration (0.21–1.0). Designed for early respiratory support, post-extubation management, and as a bridge to escalation in acute hypoxemic respiratory failure.6
Incubators maintain the thermal environment premature infants cannot yet regulate themselves.
Closed and hybrid incubator system for preterm and critically ill neonates. Servo-controlled thermoregulation (air mode and skin servo), integrated humidity management, and low-noise environment design. Full radiant warmer conversion for resuscitation.
The foundational evidence for modern ICU ventilation strategy derives from the landmark ARDSNet trial, which demonstrated that lung-protective ventilation using lower tidal volumes reduced mortality in ARDS by approximately 9% absolute risk reduction.1 ECMO for severe respiratory failure is supported by the CESAR trial2 and the EOLIA trial.3 Optimal CRRT dosing was established by the VA/NIH ATN study4 and the RENAL study,5 both finding no mortality benefit from higher-intensity dosing above 20–25 mL/kg/h. High-flow nasal cannula entered the evidence base with the FLORALI trial, which demonstrated reduced intubation rates and improved survival in acute hypoxemic respiratory failure.6
IMPORTANT NOTICE: TheronTech is a fictional company created for illustrative and creative purposes only. No products described on this page exist. No medical devices are being marketed, sold, or distributed. This page does not constitute medical advice, product promotion, or regulatory submission.
REGULATORY DISCLAIMER: All product names (AeraStar, CardioLink, AquaClear, PulseMap, InfuDose, FlowTherapy, NeoGuard) are fictional designations. Any resemblance to actual marketed devices is coincidental.
CLINICAL REFERENCES: The peer-reviewed references cited above are real, published studies included for educational context only. Clinicians should consult the full text of referenced studies and current institutional guidelines before making treatment decisions.
CONTACT INFORMATION: The representative listed above is a fictional character. The phone number and email address are not functional.
© 2025 TheronTech, Inc. [FICTIONAL] — All rights reserved.